Search Results
Results found for "GREGORY TALL"
- A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
Table 1. Table 2. molecules tested, and their pKi values compared to literature data in Table 2 . Table 3. M.; Roux, T.; Cottet, M.; Durroux, T.; Douzon, S.; Bdioui, S.; Gregor, N.; Bourrier, E.; Oueslati, N.
- Differential binding of Δ9-tetrahydrocannabinol derivatives to type 1 cannabinoid receptors (CB1)
the receptors the effects are different depending on which signaling pathway is activated, which is called The data obtained is comparable to those reported in radioligand binding assays (Table 1). Δ9-THC, Δ9-THCA and Δ9-THCV.Data represent the mean ± SEM (n = 5 in triplicates) Table
- Competitive vs Non-Competitive GPCR Antagonists: How to Interpret Pharmacology Data with Confidence
protein coupled receptor signaling in its physiological cellular context” symposium and our featured talk Solve the problem of information overload by getting a curated summary of the key talks and discussions Avoid the professional threat of falling behind your peers by accessing the same insights that are driving lessons, classified industry news, priority event alerts, job opportunities, and insider commentary—all Don’t Fall Behind—Access the Edge You Need 👉 Become a Premium Member Today ➤ Already a Premium Member
- Embark on a GPCR Adventure: Your Weekly Research Expedition! | Oct 21-27, 2024
Thank you to all participants in Dr. Terry Kenakin's educational initiative this fall! GPCR News Let’s dive into the Classified GPCR News from October 21st to 27th, 2024 Industry News Call
- Curve Shifts Don’t Lie, But Your Eyes Might
You need statistical methods that tell you, with confidence, whether the effect you’re seeing is real What you need is a number that tells you whether those differences are real. When Curves Shift Some of the most difficult calls in pharmacology happen when two curves look slightly Straight Lines, Slopes, and Systems Not all data bends into curves. , you’re leaving risk on the table.
- Intermolecular Interactions in G Protein-Coupled Receptor Allosteric Sites at the Membrane Interface
Interface from Molecular Dynamics Simulations and Quantum Chemical Calculations "Allosteric modulators are called raises many questions about the ligand interactions and stability, the binding site structure, and how all Although ligand-lipid interactions are weak, lipid tails play a role in ligand binding pose stability
- Why Kinetics Matter More Than Kd in GPCR Drug Discovery
decision you make shapes your entire pipeline trajectory—and understanding when equilibrium affinity falls All curated for speed, relevance, and immediate application—only for Premium Members. Terry Kenakin’s featured talk on “The Kinetics of Allostery” offers a rare live glimpse into advanced Don’t Fall Behind—Access the Edge You Need 👉 Ready to sharpen your discovery decisions? Access this week’s full Premium Edition here ➤ Access all the news and upcoming events Hashtags: #
- 📰 GPCR Weekly News, September 18 to 24, 2023
If you couldn't make it, no sweat – our premium members can always go back and watch the recorded talks Short talk selections will be announced soon. Abstract submissions close on October 2nd. All information is available on the Logo Contest page. Program Receives €4 Million Grant Confo Therapeutics Appoints Stephen Dowd As Chief Business Officer Call
- Adhesion GPCR Consortium Newsletter - May 2024
The family of adhesion GPCRs called the Latrophilins or ADGRLs first captured my attention due to their through a suggestion from one of my colleagues to join this select group, which was getting together to talk I still remember entering the Hall at Boston ́s Children Hospital, going to register and being asked Also, seeing the expanding diversity among the aGPCR community, added to the fact that this will all PMID 38421639 Systematic assessment of the tethered agonist-dependent activities of all 33 aGPCRs in
- 📢 Early Bird Registration Ends Tomorrow! | Sep 16 - 22, 2024
Su , et al. for their fantastic work on Germline mutations in a G protein identify signaling cross-talk Biosciences, INC as a Preferred Supplier at Prendio Crinetics Pharmaceuticals announces executive departure Call research position GPCR Activation and Signaling Germline mutations in a G protein identify signaling cross-talk
- Are You Guessing or Forecasting? Master GPCR Pharmacologic Models Before It’s Too Late
Hi GPCR Fanatics, This week’s insights will help you avoid wasted time, poor forecasts, and stalled Let’s get you moving with confidence. 🔍 Quick Wins This Week 🔹 Tell us what matters → News Survey Elevate your strategy → Building clarity in GPCR drug discovery Even the strongest GPCR programs stall—not
- Embark on a GPCR Adventure: Your Weekly Research Expedition! | Oct 21-27, 2024
Thank you to all participants in Dr. Terry Kenakin's educational initiative this fall! We thank all participants for their inspiring contributions and passion. important drug breakthroughs ever Goldman-backed drug developer Septerna raises $288 mln in US IPO Call
- 📰 GPCR Weekly News, August 7 to 13, 2023
Submit your abstracts for poster presentation using this form - short talks will be selected from these GPCR Activation and Signaling Tail engagement of arrestin at the glucagon receptor Gα protein signaling
- Assay Volume Control: Your GPCR Drug Discovery Power Lever
." — DrGPCR University Attendee 🚀 Make better calls with better inputs. . ➤ 🎓 Full GPCR University + 🔬 200+ expert talks 🗞️ Weekly research, careers & event intelligence
- What If the Most Important Part of Your Drug Isn’t What It Binds—But What It Does?
The answer lies in a misunderstood property called efficacy—the power of a drug to trigger a response
- Purpose-Driven Opioid Research: Catherine Demery’s Academic Path
For others, it’s a calling. The work no longer felt like an assignment—it felt like a calling. Catherine’s story shows that when purpose drives research, science becomes more than a job—it becomes a calling
- Dr. GPCR Summit 2022 is coming!
💡Trainees are invited to participate by presenting a trainee talk, a poster, or a pre-recorded talk
- Understanding Enzyme Inhibition In GPCR Discovery Programs
He argues that early-career researchers often fall into the trap of over-rationalizing too soon—missing Become a Premium Member today. ➤ 🎓 Full GPCR University + 🔬 200+ expert talks 🗞️ Weekly research,
- The Hidden Driver of GPCR Drug Success: Why Target Residence Time Matters More Than You Think
understand how two mechanisms intersect—and why pharmacologists are critical in addressing this crisis ➤ Call signals today will lead tomorrow’s breakthroughs—and avoid delays others won’t see coming. 👉 Don’t Fall
- Biphasic activation of β-arrestin 1 upon interaction with a GPCR revealed by methyl-TROSY NMR
function of G protein-coupled receptors (GPCRs). βarrs typically interact with phosphorylated C-terminal tail (C tail) and transmembrane core (TM core) of GPCRs. However, the effects of the C tail- and TM core-mediated interactions on the conformational activation Here, we show the conformational changes for βarr activation upon the C tail- and TM core-mediated interactions Our NMR analyses demonstrated that while the C tail-mediated interaction alone induces partial activation
- GPCR News Flash! Top Updates You Can't-Miss! + University CheatSheet is finally available! ❄ Dec 2 - 8, 2024
Dive into our courses, talks, poster presentations, and more! announce that we've been working tirelessly to bring you a simple, beautiful, and insightful collection of all This is your last call before the curtain drops: Classified GPCR News is going VIP-only next year! That's right, all the tidbits below will be for Premium Members ' eyes only.
- Why Sokhom Pin Never Left GPCRs, Even When Everyone Else Did
Scientific fads rise and fall.
- 📰 GPCR Weekly News, September 11 to 17, 2023
If you have registered, please submit poster abstracts through this form and the short talk selections Targeted and Immuno-oncology Sosei Heptares Adds World-leading Expertise to its Scientific Advisory Board Call
- From Ox Liver to AI: How the History of Pharmacology Shapes Its Future
Fast-forward a few thousand years, and we’re talking beta receptors, receptor theory, and AI-generated All of it connected. All of it is essential. Dr.
- 📰 GPCR Weekly News, August 28 to September 3, 2023
You can submit your poster abstracts using this form and short talks will be selected from abstracts. Global Healthcare Conference CEO Raymond Stevens to Speak at STAT Future Summit on Obesity Therapeutics Call
- 📰 GPCR Weekly News, July 31 to August 6, 2023
Randy Hall's study: GPR37L1's role in shaping cortical astrocytes during development Dr. Research Collaboration Addex Therapeutics To Release Half-Year 2023 Financial Results And Host Conference Call
- From Snapshots to Predictions: Why Mechanism of Action Matters
And here’s the danger: if you can’t tell how a drug is working, every downstream decision—SAR, lead When Two Mechanisms Look the Same Some of the most difficult calls in pharmacology happen when two different Without the right model, it’s like staring at identical twins—you can’t tell them apart until you see That could be: An orthosteric partial agonist , or An allosteric partial agonist The raw data won’t tell When data alone are ambiguous, models tell you which parameters to control, which conditions to vary,
- Fly casting with ligand sliding and orientational selection supporting complex formation of a GPCR..
All molecular components (bosentan, hETB, membrane, and solvent) were represented with an all-atom model bosentan fluctuating randomly in solution is captured using a tip region of the flexible N-terminal tail Bosentan then slides occasionally from the tip to the root of the N-terminal tail (ligand–sliding). The bosentan-captured conformations by the tip-region and root-region of the N-terminal tail correspond
- The Imprecision Problem: Why Your GPCR Drug Discovery Program Is Off-Track Before It Even Starts
Hiring Won’t Save Your GPCR Drug Discovery Program When a drug discovery program stalls, the default Ambiguous Decision Gates: Molecules advance or stall based on vibes, not criteria.
- How Understanding Intracellular Drug Access Can Transform Your GPCR Drug Discovery Program
Expand your computational toolkit ➤ Call for Papers: GPCRs: Signal Transduction, Volume II Building on Don’t Fall Behind—Access the Edge You Need 👉 Access all the news and upcoming events ➤ 👉 Already a






















